2016 Q1 Form 10-K Financial Statement

#000114420416091575 Filed on March 30, 2016

View on sec.gov

Income Statement

Concept 2016 Q1 2015 2014 Q4
Revenue $9.125K $628.9K $80.00K
YoY Change -95.06% 51.18%
Cost Of Revenue $10.00 $261.5K $110.0K
YoY Change -99.99% 22.29%
Gross Profit $9.115K $367.4K -$30.00K
YoY Change -91.6% 81.74%
Gross Profit Margin 99.89% 58.42% -37.5%
Selling, General & Admin $1.210M $5.433M $940.0K
YoY Change -9.02% 47.07%
% of Gross Profit 13274.82% 1478.65%
Research & Development $866.0K $2.105M $350.0K
YoY Change 112.86% 47.14%
% of Gross Profit 9501.31% 572.94%
Depreciation & Amortization $62.39K $213.8K $30.00K
YoY Change 57.5% 121.11%
% of Gross Profit 684.5% 58.19%
Operating Expenses $2.076M $7.538M $1.290M
YoY Change 19.71% 47.09%
Operating Profit -$2.067M -$7.170M -$1.320M
YoY Change 27.13% 45.66%
Interest Expense $42.84K $263.6K -$150.0K
YoY Change -33.73% -7.6%
% of Operating Profit
Other Income/Expense, Net -$420.2K -$753.1K -$20.00K
YoY Change 213.22% 13.23%
Pretax Income -$2.490M -$7.768M -$1.480M
YoY Change 41.48% 48.7%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.487M -$7.923M -$1.480M
YoY Change 41.32% 41.8%
Net Earnings / Revenue -27258.39% -1259.87% -1850.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$687.8K -$3.204M -$925.0K
COMMON SHARES
Basic Shares Outstanding 3.926M shares 31.46M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q1 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $350.0K $166.6K $90.00K
YoY Change 133.33% 81.44%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $20.00K $29.35K $20.00K
YoY Change -33.33% 42.68%
Inventory $1.945K
Prepaid Expenses
Receivables $9.000K $93.38K $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $384.2K $289.3K $114.3K
YoY Change 113.15% 153.07% -52.33%
LONG-TERM ASSETS
Property, Plant & Equipment $599.4K $643.1K $493.9K
YoY Change 11.59% 30.22% 1288.48%
Goodwill
YoY Change
Intangibles $1.020M $1.038M
YoY Change -6.84% -6.3%
Long-Term Investments
YoY Change
Other Assets $50.00K $45.90K $50.00K
YoY Change 0.0% 0.0%
Total Long-Term Assets $1.665M $1.728M $1.577M
YoY Change -0.75% 9.52% 38.0%
TOTAL ASSETS
Total Short-Term Assets $384.2K $289.3K $114.3K
Total Long-Term Assets $1.665M $1.728M $1.577M
Total Assets $2.049M $2.017M $1.692M
YoY Change 10.29% 19.22% 22.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.194M $2.549M $1.112M
YoY Change 73.37% 129.25% -12.45%
Accrued Expenses $2.045M $2.054M $1.467M
YoY Change 8.49% 31.6% 24.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.320M $1.010M $5.690M
YoY Change -75.82% -82.25%
Total Short-Term Liabilities $5.590M $5.612M $8.525M
YoY Change -37.35% -34.16% 13.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $302.0K $50.00K
YoY Change -100.0% 504.0%
Other Long-Term Liabilities $0.00 $11.01K $10.00K
YoY Change -100.0% 111.73%
Total Long-Term Liabilities $0.00 $313.0K $60.00K
YoY Change -100.0% 467.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.590M $5.612M $8.525M
Total Long-Term Liabilities $0.00 $313.0K $60.00K
Total Liabilities $5.590M $5.925M $8.580M
YoY Change -39.57% -30.94% 6.35%
SHAREHOLDERS EQUITY
Retained Earnings -$35.81M -$25.40M
YoY Change 31.85% 28.2%
Common Stock $3.959K $1.726K
YoY Change -91.21%
Preferred Stock
YoY Change
Treasury Stock (at cost) $32.00K $32.00K
YoY Change 0.0%
Treasury Stock Shares 27.93K shares 27.93K shares
Shareholders Equity -$3.541M -$3.908M -$6.888M
YoY Change
Total Liabilities & Shareholders Equity $2.049M $2.017M $1.692M
YoY Change 10.19% 19.22% 22.34%

Cashflow Statement

Concept 2016 Q1 2015 2014 Q4
OPERATING ACTIVITIES
Net Income -$2.487M -$7.923M -$1.480M
YoY Change 41.32% 41.8%
Depreciation, Depletion And Amortization $62.39K $213.8K $30.00K
YoY Change 57.5% 121.11%
Cash From Operating Activities -$1.720M -$3.122M -$640.0K
YoY Change 156.72% -3.28%
INVESTING ACTIVITIES
Capital Expenditures $89.87K $408.1K -$170.0K
YoY Change -2.5% 142.36%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$75.00K $0.00
YoY Change -100.0% -7753.06%
Cash From Investing Activities -$90.00K -$483.1K -$170.0K
YoY Change -47.06% 188.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.990M 3.680M 520.0K
YoY Change 121.11% 11.99%
NET CHANGE
Cash From Operating Activities -1.720M -3.122M -640.0K
Cash From Investing Activities -90.00K -483.1K -170.0K
Cash From Financing Activities 1.990M 3.680M 520.0K
Net Change In Cash 180.0K 74.76K -290.0K
YoY Change 200.0% -168.4%
FREE CASH FLOW
Cash From Operating Activities -$1.720M -$3.122M -$640.0K
Capital Expenditures $89.87K $408.1K -$170.0K
Free Cash Flow -$1.810M -$3.530M -$470.0K
YoY Change 137.46% 3.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2015 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2015 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2015 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q2 dei Entity Public Float
EntityPublicFloat
12835315 USD
CY2015 dei Trading Symbol
TradingSymbol
BRTX
CY2016Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3925818 shares
CY2015Q4 us-gaap Cash
Cash
166555 USD
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
29348 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
22515 USD
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Assets Current
AssetsCurrent
289278 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
114313 USD
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
643087 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
493856 USD
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1038741 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1037732 USD
CY2015Q4 us-gaap Assets
Assets
2017006 USD
CY2014Q4 us-gaap Assets
Assets
1691801 USD
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2549042 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1111879 USD
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2046795 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1466506 USD
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6823 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
94026 USD
CY2015Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1009797 USD
CY2014Q4 us-gaap Notes Payable Current
NotesPayableCurrent
5688239 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5612457 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8524999 USD
CY2015Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
11011 USD
CY2014Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
5195 USD
CY2015Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
302001 USD
CY2014Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
50000 USD
CY2015Q4 us-gaap Liabilities
Liabilities
5925469 USD
CY2014Q4 us-gaap Liabilities
Liabilities
8580194 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
3339 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
1726 USD
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29443704 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18541907 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33323506 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25400026 USD
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
32000 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
32000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-3908463 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-6888393 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2017006 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1691801 USD
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
164349 USD
CY2015Q4 us-gaap Security Deposit
SecurityDeposit
45900 USD
CY2014Q4 us-gaap Security Deposit
SecurityDeposit
45900 USD
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015 us-gaap Revenues
Revenues
628915 USD
CY2014 us-gaap Revenues
Revenues
415996 USD
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
261504 USD
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
213834 USD
CY2015 us-gaap Gross Profit
GrossProfit
367411 USD
CY2014 us-gaap Gross Profit
GrossProfit
202162 USD
CY2015 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
168352 USD
CY2014 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
125626 USD
CY2015 us-gaap Professional Fees
ProfessionalFees
1394037 USD
CY2014 us-gaap Professional Fees
ProfessionalFees
1310121 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2258307 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
7537773 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
5124668 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-7170362 USD
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-4922506 USD
CY2015 us-gaap Interest Expense
InterestExpense
263583 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2105059 USD
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1430614 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3870325 USD
CY2014 us-gaap Interest Expense
InterestExpense
285275 USD
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
339443 USD
CY2014 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
464470 USD
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-35677 USD
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-49094 USD
CY2015 brtx Warrant Modification Expense
WarrantModificationExpense
114415 USD
CY2014 brtx Warrant Modification Expense
WarrantModificationExpense
50035 USD
CY2015 brtx Gain Loss Related To Settlement Of Note And Payables
GainLossRelatedToSettlementOfNoteAndPayables
0 USD
CY2014 brtx Gain Loss Related To Settlement Of Note And Payables
GainLossRelatedToSettlementOfNoteAndPayables
183768 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-753118 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-665106 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-7923480 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-5587612 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.20
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.38
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2472889 shares
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1276904 shares
CY2014 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
96685 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
213784 USD
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1009 USD
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
1360296 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1954736 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-11832 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6833 USD
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-234563 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1381407 USD
CY2014 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
0 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1022813 USD
CY2014 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
2359761 USD
CY2015 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
4801417 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3227851 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3122063 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
168376 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
408069 USD
CY2014 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
980 USD
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-167396 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-483069 USD
CY2014 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
795000 USD
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1210015 USD
CY2015 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5000 USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
58054 USD
CY2015 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
564105 USD
CY2014 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
83044 USD
CY2014 us-gaap Accretion Expense
AccretionExpense
24934 USD
CY2015 brtx Warrant Modification Extension Expense
WarrantModificationExtensionExpense
114415 USD
CY2014 brtx Warrant Modification Extension Expense
WarrantModificationExtensionExpense
50035 USD
CY2015 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0 USD
CY2014 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
45900 USD
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-81387 USD
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
585881 USD
CY2015 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
387075 USD
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
113000 USD
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
264144 USD
CY2014 brtx Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
2605000 USD
CY2015 us-gaap Interest Paid
InterestPaid
61453 USD
CY2014 us-gaap Interest Paid
InterestPaid
127112 USD
CY2015 brtx Conversion Of Notes Payable And Accruedinterest In To Common Stock
ConversionOfNotesPayableAndAccruedinterestInToCommonStock
238508 USD
CY2014 brtx Conversion Of Notes Payable And Accruedinterest In To Common Stock
ConversionOfNotesPayableAndAccruedinterestInToCommonStock
359711 USD
CY2015 brtx Reclassification Of Accrued Interest In Connection With Note Payable Issuance
ReclassificationOfAccruedInterestInConnectionWithNotePayableIssuance
44379 USD
CY2014 brtx Reclassification Of Accrued Interest In Connection With Note Payable Issuance
ReclassificationOfAccruedInterestInConnectionWithNotePayableIssuance
108059 USD
CY2015 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
87788 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3679889 USD
CY2014 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-109300 USD
CY2015 us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
74757 USD
CY2013Q4 us-gaap Cash
Cash
201098 USD
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
164349 USD
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-164349 USD
CY2015 brtx Payments To License Maintenance Costs
PaymentsToLicenseMaintenanceCosts
75000 USD
CY2014 brtx Payments To License Maintenance Costs
PaymentsToLicenseMaintenanceCosts
0 USD
CY2015 us-gaap Accretion Expense
AccretionExpense
85086 USD
CY2014 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
92370 USD
CY2014 brtx Indebtedness Satisfied Via Legal Settlement
IndebtednessSatisfiedViaLegalSettlement
0 USD
CY2015 brtx Indebtedness Satisfied Via Legal Settlement
IndebtednessSatisfiedViaLegalSettlement
5000 USD
CY2015 brtx Conversion Of Debt Amount Converted
ConversionOfDebtAmountConverted
65000 USD
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2033700 USD
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
238508 USD
CY2015 brtx Shares Issued In Satisfaction Of Accrued Interest
SharesIssuedInSatisfactionOfAccruedInterest
8481 USD
CY2015 brtx Stocks And Warrants Issued During Period Value In Connection With Settlement Agreement
StocksAndWarrantsIssuedDuringPeriodValueInConnectionWithSettlementAgreement
152000 USD
CY2015 brtx Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
2033700 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3285947 USD
CY2015 brtx Stocks And Warrants Issued During Period Value In Exchange Of Debt
StocksAndWarrantsIssuedDuringPeriodValueInExchangeOfDebt
5755872 USD
CY2015 brtx Warrant Modification Charge
WarrantModificationCharge
229288 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
177647 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1777089 USD
CY2015 brtx Share Rounding Dueto Reverse Stock Value Split
ShareRoundingDuetoReverseStockValueSplit
0 USD
CY2015Q4 brtx Working Capital Net
WorkingCapitalNet
5323179 USD
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1224317 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2546088 shares
CY2015Q4 brtx Credit Card Payable Current
CreditCardPayableCurrent
3171 USD
CY2014Q4 brtx Credit Card Payable Current
CreditCardPayableCurrent
4739 USD
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1010633 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
679277 USD
CY2015Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
43604 USD
CY2014Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
0 USD
CY2015Q4 brtx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
446175 USD
CY2014Q4 brtx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
292395 USD
CY2015Q4 brtx Accrued General And Administrative Expenses
AccruedGeneralAndAdministrativeExpenses
456182 USD
CY2014Q4 brtx Accrued General And Administrative Expenses
AccruedGeneralAndAdministrativeExpenses
315294 USD
CY2015Q4 brtx Accrued Purchase Of Property And Equipment
AccruedPurchaseOfPropertyAndEquipment
0 USD
CY2014Q4 brtx Accrued Purchase Of Property And Equipment
AccruedPurchaseOfPropertyAndEquipment
174801 USD
CY2015Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
87030 USD
CY2014Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2015 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
65000 USD
CY2015Q4 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
75000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.56
CY2015 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2015-10-30
CY2015Q4 us-gaap Notes Payable
NotesPayable
1311798 USD
CY2015 brtx Note Payable Principal Issued
NotePayablePrincipalIssued
1363018 USD
CY2015 us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
5000 USD
CY2015 brtx Exchanges For Equity
ExchangesForEquity
5555477 USD
CY2015 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
223333 USD
CY2015 brtx Recognition Of Debt Discount
RecognitionOfDebtDiscount
469557 USD
CY2013Q4 us-gaap Notes Payable
NotesPayable
5514009 USD
CY2014Q4 us-gaap Notes Payable
NotesPayable
5738239 USD
CY2014 brtx Note Payable Principal Issued
NotePayablePrincipalIssued
800000 USD
CY2014 brtx Recognition Of Debt Discount
RecognitionOfDebtDiscount
347170 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
586250 shares
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
35000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1330450 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
679577 shares
CY2015 brtx Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y10M24D
CY2015Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.14
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.34
CY2015 us-gaap Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
31473 shares
CY2015 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
112847 USD
CY2015Q1 brtx Class Of Warrant Or Rightst Expiration Date
ClassOfWarrantOrRightstExpirationDate
2015-12-31
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
93375 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 USD
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the periods. The Company&#8217;s significant estimates and assumptions include the recoverability and useful lives of long-lived assets, the fair value of the Company&#8217;s stock, stock-based compensation, warrants issued in connection with notes payable and the valuation allowance related to the Company&#8217;s deferred tax assets. Certain of the Company&#8217;s estimates, including the carrying amount of the intangible assets, could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company&#8217;s estimates and could cause actual results to differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Concentrations and Credit Risk</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Two pharmaceutical clients comprised substantially all of the Company&#8217;s revenue during the years ended December 31, 2015 and 2014. See Revenue Recognition &#150; Research and Development Agreements below.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3338661 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1725596 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3310729 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1697664 shares
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
27932 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
27932 shares
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
93375 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2015Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company implemented a 1-for-20 reverse split
CY2015Q4 brtx Office Equipment Gross
OfficeEquipmentGross
9494 USD
CY2014Q4 brtx Office Equipment Gross
OfficeEquipmentGross
8466 USD
CY2015Q4 brtx Medical Equipment Gross
MedicalEquipmentGross
418280 USD
CY2014Q4 brtx Medical Equipment Gross
MedicalEquipmentGross
359248 USD
CY2015Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
126150 USD
CY2014Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
113874 USD
CY2015Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
85118 USD
CY2014Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
66458 USD
CY2015Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
301610 USD
CY2014Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
103582 USD
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
940652 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
651628 USD
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
297565 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
157772 USD
CY2015 us-gaap Depreciation
Depreciation
139793 USD
CY2014 us-gaap Depreciation
Depreciation
26872 USD
CY2014 brtx Exchanges For Equity
ExchangesForEquity
274000 USD
CY2014 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
342500 USD
CY2014 brtx Settlement Of Accreted Interest
SettlementOfAccretedInterest
7500 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-6685069 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2605000 USD
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
359711 USD
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1107545 USD
CY2014 brtx Intangible Assets Amortization Expense
IntangibleAssetsAmortizationExpense
69813 USD
CY2015 brtx License Agreement Expenses
LicenseAgreementExpenses
75000 USD
CY2015 brtx Intangible Assets Amortization Expense
IntangibleAssetsAmortizationExpense
73991 USD
CY2015 us-gaap Adjustment For Amortization
AdjustmentForAmortization
75000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7767924 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-5223749 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-155556 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-363863 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7923480 USD
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5587612 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1181900 USD
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4820500 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1976600 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1272600 USD
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
231100 USD
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
240700 USD
CY2015Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
139480 USD
CY2014Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
95500 USD
CY2015Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2100 USD
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2100 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3531180 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
6431400 USD
CY2015Q4 brtx Deferred Tax Liabilities Fixed Asset Depreciation
DeferredTaxLiabilitiesFixedAssetDepreciation
110300 USD
CY2014Q4 brtx Deferred Tax Liabilities Fixed Asset Depreciation
DeferredTaxLiabilitiesFixedAssetDepreciation
93200 USD
CY2015Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
13400 USD
CY2014Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
8100 USD
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
123700 USD
CY2014Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
101300 USD
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3407480 USD
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
6330100 USD
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3407480 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6330100 USD
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2614976 USD
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
38921 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
307644 USD
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
4579 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 brtx Income Tax Expense Benefit Continuing Operations Before Change In Valuation Allowance
IncomeTaxExpenseBenefitContinuingOperationsBeforeChangeInValuationAllowance
2922620 USD
CY2014 brtx Income Tax Expense Benefit Continuing Operations Before Change In Valuation Allowance
IncomeTaxExpenseBenefitContinuingOperationsBeforeChangeInValuationAllowance
43500 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.040 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.040 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.008 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.008 pure
CY2014 brtx Effective Income Tax Rate Reconciliation Tax Credits Research And Development
EffectiveIncomeTaxRateReconciliationTaxCreditsResearchAndDevelopment
-0.018 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.412 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.014 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.008 pure
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2015Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
3100000 USD
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12700000 USD
CY2015Q4 brtx Percentage Of Ownership Changes
PercentageOfOwnershipChanges
0.5 pure
CY2015 us-gaap Advertising Expense
AdvertisingExpense
23467 USD
CY2014 us-gaap Advertising Expense
AdvertisingExpense
15280 USD
CY2015 brtx Operating Loss Carry Forwards Expiration Period
OperatingLossCarryForwardsExpirationPeriod
The net operating loss carry forwards, if not utilized, will expire from 2029 to 2035 for federal purposes
CY2015Q4 brtx Lease Rent Second Year
LeaseRentSecondYear
6234 USD
CY2015Q4 brtx Lease Rent Third Year
LeaseRentThirdYear
6422 USD
CY2014Q1 brtx Monthly Payments For Leasing
MonthlyPaymentsForLeasing
962 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
141131 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
20380 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
112000 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
43000 USD
CY2011Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2014-01-31
CY2015 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
25000 USD
CY2015 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
6250 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
6250 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.00
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
11063 USD
CY2014 brtx Recharacterization Of Accrued Interest As Principal
RecharacterizationOfAccruedInterestAsPrincipal
108059 USD
CY2015 brtx Recharacterization Of Accrued Interest As Principal
RecharacterizationOfAccruedInterestAsPrincipal
44379 USD
CY2014Q4 brtx Percentage Of Increase Salary
PercentageOfIncreaseSalary
0.28 pure
CY2014Q4 brtx Salaries And Wages Initial Year
SalariesAndWagesInitialYear
25000 USD
CY2014Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2420 USD
CY2014Q4 brtx Monthly Payments Under Consulting Agreements
MonthlyPaymentsUnderConsultingAgreements
15000 USD
CY2015Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
150000 USD
CY2015Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.1 pure
CY2015Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2016-03-09
CY2015Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
239182 shares
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
15.00
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
4.00
CY2015Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
98739 USD
CY2015Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
150000 USD
CY2015 brtx Warrants Expiration Period
WarrantsExpirationPeriod
P5Y
CY2015Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
797576 USD
CY2014Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
574278 USD
CY2015 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
5000 USD
CY2014 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
113000 USD
CY2015Q3 brtx Stockholders Equity Note Changes In Capital Structure Retroactive Impact Shares
StockholdersEquityNoteChangesInCapitalStructureRetroactiveImpactShares
200000000 shares
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2250000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
2250000 shares
CY2014Q4 brtx Warrant To Purchase Common Stock Issued In Period
WarrantToPurchaseCommonStockIssuedInPeriod
116535 shares
CY2014Q4 brtx Warrant To Purchase Common Stock Issued In Period Exercise Price
WarrantToPurchaseCommonStockIssuedInPeriodExercisePrice
6.00
CY2014Q4 brtx Warrants Aggregate Grant Date Fair Value
WarrantsAggregateGrantDateFairValue
389608 USD
CY2015Q4 brtx Warrant To Purchase Common Stock Issued In Period
WarrantToPurchaseCommonStockIssuedInPeriod
259464 shares
CY2015Q4 brtx Warrant To Purchase Common Stock Issued In Period Exercise Price
WarrantToPurchaseCommonStockIssuedInPeriodExercisePrice
5.00
CY2015Q4 brtx Warrants Aggregate Grant Date Fair Value
WarrantsAggregateGrantDateFairValue
611730 USD
CY2015 brtx Warrants Issued During Period Number Of Warrants
WarrantsIssuedDuringPeriodNumberOfWarrants
125000 shares
CY2015Q4 brtx Warrants Issued During Period Exercise Price
WarrantsIssuedDuringPeriodExercisePrice
5.00
CY2013Q4 brtx Warrant To Purchase Common Stock Issued In Period Exercise Price
WarrantToPurchaseCommonStockIssuedInPeriodExercisePrice
6.00
CY2013Q4 brtx Exercise Price Of Redeemable Warrant To Be Issued
ExercisePriceOfRedeemableWarrantToBeIssued
15.00
CY2014 brtx Warrants Excluded From Computation Of Weighted Average Price Of Warrants Granted
WarrantsExcludedFromComputationOfWeightedAveragePriceOfWarrantsGranted
18833 shares
CY2014 brtx Warrant Modification Charge
WarrantModificationCharge
50035 USD
CY2013Q4 brtx Warrant Redemption Terms
WarrantRedemptionTerms
The terms of the newly issued warrant permit the Company to redeem the new warrant for a total of $1.00 if the common stock of the Company trades above $25.00 for five consecutive trading days.
CY2015 brtx Share Based Compensations Exercise Price Range Exercisable Warrant Weighted Average Remaining Contractual Term
ShareBasedCompensationsExercisePriceRangeExercisableWarrantWeightedAverageRemainingContractualTerm
P4Y
CY2015Q4 brtx Share Based Compensation Exercise Price Range Number Of Outstanding Warrants
ShareBasedCompensationExercisePriceRangeNumberOfOutstandingWarrants
1066930 shares
CY2015Q4 brtx Share Based Compensation Exercise Price Range Number Of Exercisable Warrants
ShareBasedCompensationExercisePriceRangeNumberOfExercisableWarrants
1031930 shares
CY2015Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1330450 shares
CY2015 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2015Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
679577 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.07
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.40
CY2015 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2014 us-gaap Inventory Write Down
InventoryWriteDown
15407 USD
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-2922620 USD
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-43500 USD
CY2015Q4 brtx Debt Instrument Unamortized Debt Discount Current Portion
DebtInstrumentUnamortizedDebtDiscountCurrentPortion
150286 USD
CY2014Q4 brtx Debt Instrument Unamortized Debt Discount Current Portion
DebtInstrumentUnamortizedDebtDiscountCurrentPortion
113257 USD
CY2014 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
140000 USD
CY2014 brtx Stocks And Warrants Issued During Period Value In Leasehold Improvements
StocksAndWarrantsIssuedDuringPeriodValueInLeaseholdImprovements
71050 USD
CY2014 brtx Stocks And Warrants Issued During Period Value In Exchange Of Debt
StocksAndWarrantsIssuedDuringPeriodValueInExchangeOfDebt
343026 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
249800 USD
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
300784 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1059512 USD
CY2015 brtx Adjustments To Additional Paid In Capital Shares And Warrants Issued As Debt Discount Value
AdjustmentsToAdditionalPaidInCapitalSharesAndWarrantsIssuedAsDebtDiscountValue
178893 USD
CY2014 brtx Conversion Of Debt Amount Converted
ConversionOfDebtAmountConverted
0 USD
CY2016Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
21865 USD
CY2014Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2014-07-31
CY2015 brtx Description For Section382 Limitation One
DescriptionForSection382LimitationOne
approximately $15,500,000 and $5,700,000, respectively,of federal NOLs not being realizable
CY2015 brtx Description For Section382 Limitation Two
DescriptionForSection382LimitationTwo
the reversal of approximately $5,900,000 and $2,200,000, respectively,of net operating loss deferred tax assets
CY2015Q4 brtx Debt Instrument Unamortized Debt Discount Noncurrent Portion
DebtInstrumentUnamortizedDebtDiscountNoncurrentPortion
7999 USD
CY2014Q4 brtx Debt Instrument Unamortized Debt Discount Noncurrent Portion
DebtInstrumentUnamortizedDebtDiscountNoncurrentPortion
0 USD
CY2015 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <u><font style="FONT-SIZE: 10pt">Reclassification</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">Certain amounts in prior periods have been reclassified to conform to the current period presentation. These reclassifications had no effect on previously reported net loss</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015Q1 brtx Milestones Payment
MilestonesPayment
75000 USD
CY2016Q1 brtx Warrants Issued During Period Number Of Warrants
WarrantsIssuedDuringPeriodNumberOfWarrants
15000 shares
CY2016Q1 brtx Warrants Issued During Period Exercise Price
WarrantsIssuedDuringPeriodExercisePrice
3.70
CY2015 brtx Accrued Purchases Of Property And Equipment
AccruedPurchasesOfPropertyAndEquipment
139729 USD
CY2014 brtx Accrued Purchases Of Property And Equipment
AccruedPurchasesOfPropertyAndEquipment
258774 USD
CY2015 brtx Effective Income Tax Rate Reconciliation Tax Credits Research And Development
EffectiveIncomeTaxRateReconciliationTaxCreditsResearchAndDevelopment
-0.006 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.760 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.006 pure
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.376 pure
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
779200 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.18

Files In Submission

Name View Source Status
0001144204-16-091575-index-headers.html Edgar Link pending
0001144204-16-091575-index.html Edgar Link pending
0001144204-16-091575.txt Edgar Link pending
0001144204-16-091575-xbrl.zip Edgar Link pending
brtx-20151231.xml Edgar Link completed
brtx-20151231.xsd Edgar Link pending
brtx-20151231_cal.xml Edgar Link unprocessable
brtx-20151231_def.xml Edgar Link unprocessable
brtx-20151231_lab.xml Edgar Link unprocessable
brtx-20151231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg15a.jpg Edgar Link pending
tpg15b.jpg Edgar Link pending
tpg15c.jpg Edgar Link pending
tpg9.jpg Edgar Link pending
v434828_10k.htm Edgar Link pending
v434828_ex10-20.htm Edgar Link pending
v434828_ex10-61.htm Edgar Link pending
v434828_ex10-64.htm Edgar Link pending
v434828_ex10-65.htm Edgar Link pending
v434828_ex10-66.htm Edgar Link pending
v434828_ex23.htm Edgar Link pending
v434828_ex31-1.htm Edgar Link pending
v434828_ex31-2.htm Edgar Link pending
v434828_ex32.htm Edgar Link pending